Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,703 | 5,253 | 6,195 | 3,476 | 7,186 |
| Other current assets | 0 | 87 | 0 | 0 | 0 |
| TOTAL | $18,035 | $5,413 | $6,505 | $4,051 | $7,871 |
| Non-Current Assets | |||||
| PPE Net | 84 | 90 | 96 | 103 | 109 |
| TOTAL | $84 | $90 | $96 | $103 | $109 |
| Total Assets | $18,119 | $5,503 | $6,602 | $4,154 | $7,980 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 705 | 554 | 466 | 917 | 1,461 |
| Accrued Expenses | 974 | 986 | 996 | 2,169 | 3,706 |
| Other current liabilities | 3,511 | N/A | N/A | N/A | N/A |
| TOTAL | $8,101 | $4,451 | $4,374 | $5,997 | $8,079 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,911 | 2,911 | 2,911 | 2,911 | 2,911 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,101 | $4,451 | $4,374 | $5,997 | $8,079 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 23,536 | 23,416 | 15,083 |
| Common Shares | 5 | 0 | 24 | 15 | 15 |
| Retained earnings | -19,188 | -25,347 | -24,139 | -22,969 | -21,134 |
| TOTAL | $10,018 | $1,053 | $2,228 | $-1,843 | $-99 |
| Total Liabilities And Equity | $18,119 | $5,504 | $6,602 | $4,154 | $7,980 |